By: IPP Bureau
Last updated : April 17, 2022 6:50 pm
The company also plans to expand the facility
Evexia Lifecare has announced that it plans to start manufacturing API of Isometamidium (Isometa) from April 18th 2022 at its Vadodara plant.
The company has also decided to build over 150000 sqft plant facility at the Vadodara-based location. This facility will be in accordance with the USFDA for the manufacturing of the other APIs and Intermediate products.
The company expects new milestones with respect to the production and market share of these products. The company’s scientists are working round the clock for trials of other APIs/intermediates at the world-class facility of laboratory available at the Vadodara based location, the company said in a statement.